Athira Pharma (ATHA) just unveiled an announcement.
Athira Pharma, Inc. is set to host a webcast today at 4:30 PM Eastern time to discuss the Phase 2/3 LIFT-AD clinical trial’s topline results, accessible via their website or by phone. They have also reported a preliminary estimate of their financial position as of August 31, 2024, with cash and investments totaling about $75.1 million. However, these figures are unaudited and subject to change after further review. The company cautions that these forward-looking statements come with risks and uncertainties, and actual results may differ.
For a thorough assessment of ATHA stock, go to TipRanks’ Stock Analysis page.
